Lin Junxin, Yang Yuwei, Zhou Wenyan, Dai Chao, Chen Xiao, Xie Yuanhao, Han Shan, Liu Huanhuan, Hu Yejun, Tang Chenqi, Bunpetch Varitsara, Zhang Dandan, Chen Yishan, Zou Xiaohui, Chen Di, Liu Wanlu, Ouyang Hongwei
Dr. Li Dak Sum & Yip Yio Chin Center for Stem Cells and Regenerative Medicine, and Department of Orthopedic Surgery of the Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
Department of Sports Medicine, Zhejiang University School of Medicine, Hangzhou, China.
Bone Res. 2022 Jan 7;10(1):4. doi: 10.1038/s41413-021-00175-9.
Tendon heterotopic ossification (HO) is characterized by bone formation inside tendon tissue, which severely debilitates people in their daily life. Current therapies fail to promote functional tissue repair largely due to our limited understanding of HO pathogenesis. Here, we investigate the pathological mechanism and propose a potential treatment method for HO. Immunofluorescence assays showed that the Mohawk (MKX) expression level was decreased in human tendon HO tissue, coinciding with spontaneous HO and the upregulated expression of osteochondrogenic and angiogenic genes in the tendons of Mkx mice. Single-cell RNA sequencing analyses of wild-type and Mkx tendons identified three cell types and revealed the excessive activation of osteochondrogenic genes during the tenogenesis of Mkx tendon cells. Single-cell analysis revealed that the gene expression program of angiogenesis, which is strongly associated with bone formation, was activated in all cell types during HO. Moreover, inhibition of angiogenesis by the small-molecule inhibitor BIBF1120 attenuated bone formation and angiogenesis in the Achilles tendons of both Mkx mutant mice and a rat traumatic model of HO. These findings provide new insights into the cellular mechanisms of tendon HO and highlight the inhibition of angiogenesis with BIBF1120 as a potential treatment strategy for HO.
肌腱异位骨化(HO)的特征是在肌腱组织内形成骨,这在很大程度上使人们在日常生活中丧失能力。目前的治疗方法未能促进功能性组织修复,主要是因为我们对HO发病机制的了解有限。在此,我们研究了其病理机制,并提出了一种针对HO的潜在治疗方法。免疫荧光分析表明,在人类肌腱HO组织中,莫霍克(MKX)表达水平降低,这与自发性HO以及Mkx小鼠肌腱中骨软骨生成和血管生成基因的表达上调相一致。对野生型和Mkx肌腱进行的单细胞RNA测序分析确定了三种细胞类型,并揭示了Mkx肌腱细胞成腱过程中骨软骨生成基因的过度激活。单细胞分析表明,在HO过程中,与骨形成密切相关的血管生成基因表达程序在所有细胞类型中均被激活。此外,小分子抑制剂BIBF1120抑制血管生成可减弱Mkx突变小鼠和大鼠HO创伤模型跟腱中的骨形成和血管生成。这些发现为肌腱HO的细胞机制提供了新的见解,并突出了用BIBF1120抑制血管生成作为HO潜在治疗策略的作用。